Follow
Jovana Nazor
Jovana Nazor
Codexis Inc
Verified email at codexis.com
Title
Cited by
Cited by
Year
Design of an in vitro biocatalytic cascade for the manufacture of islatravir
MA Huffman, A Fryszkowska, O Alvizo, M Borra-Garske, KR Campos, ...
Science 366 (6470), 1255-1259, 2019
4952019
Laboratory evolution of P450 BM3 for mediated electron transfer yielding an activity-improved and reductase-independent variant
J Nazor, S Dannenmann, RO Adjei, YB Fordjour, IT Ghampson, ...
Protein Engineering, Design & Selection 21 (1), 29-35, 2008
902008
Ultra-high-throughput screening method for the directed evolution of glucose oxidase
R Ostafe, R Prodanovic, J Nazor, R Fischer
Chemistry & biology 21 (3), 414-421, 2014
782014
Baeyer–Villiger monooxygenase-mediated synthesis of esomeprazole as an alternative for kagan sulfoxidation
YK Bong, S Song, J Nazor, M Vogel, M Widegren, D Smith, SJ Collier, ...
The Journal of organic chemistry 83 (14), 7453-7458, 2018
682018
Directed evolution of glucose oxidase from Aspergillus niger for ferrocenemethanol‐mediated electron transfer
Z Zhu, M Wang, A Gautam, J Nazor, C Momeu, R Prodanovic, ...
Biotechnology Journal: Healthcare Nutrition Technology 2 (2), 241-248, 2007
682007
Laboratory evolution of P450 BM‐3 for mediated electron transfer
J Nazor, U Schwaneberg
ChemBioChem 7 (4), 638-644, 2006
662006
Enzyme evolution for industrial biocatalytic cascades
J Nazor, J Liu, G Huisman
Current Opinion in Biotechnology 69, 182-190, 2021
572021
Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
H Chen, SJ Collier, J Nazor, J Sukumaran, D Smith, JC Moore, G Hughes, ...
US Patent 9,487,760, 2016
522016
Synthesis of prazole compounds
YK Bong, MD Clay, SJ Collier, B Mijts, M Vogel, X Zhang, J Zhu, J Nazor, ...
492011
A chemoenzymatic strategy for site-selective functionalization of native peptides and proteins
A Fryszkowska, C An, O Alvizo, G Banerjee, KA Canada, Y Cao, ...
Science 376 (6599), 1321-1327, 2022
342022
Production of fatty alcohols from engineered microorganisms
K Chan, F Valle, Y Barak, L Clark, K Karlshoej, J Vroom, J Nazor, ...
US Patent 9,714,437, 2017
332017
Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
J Nazor, D Smith, M Crowe, S Song, SJ Collier
US Patent 9,139,821, 2015
162015
Polynucleotides encoding engineered imine reductases
H Chen, SJ Collier, J Nazor, J Sukumaran, D Smith, JC Moore, G Hughes, ...
US Patent 9,695,451, 2017
132017
Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
H Chen, SJ Collier, J Nazor, J Sukumaran, D Smith, JC Moore, G Hughes, ...
US Patent 9,296,993, 2016
132016
Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
H Chen, SJ Collier, J Nazor, J Sukumaran, D Smith, JC Moore, G Hughes, ...
US Patent 9,828,614, 2017
102017
Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
J Nazor, D Smith, M Crowe, S Song, SJ Collier
US Patent 9,388,395, 2016
102016
Synthesis of prazole compounds
YK Bong, MD Clay, SJ Collier, B Mijts, M Vogel, X Zhang, J Zhu, J Nazor, ...
US Patent 8,895,271, 2014
102014
Biocatalysts and methods for hydroxylation of chemical compounds
J Nazor, R Osborne, J Liang, J VROOM, X Zhang, D Entwistle, R Voladri, ...
92017
Chemical process for preparing spiroindolones and intermediates thereof
M Crowe, M Foulkes, G Francese, D Grimler, E Kuesters, K Laumen, Y Li, ...
82023
Biocatalysts and methods for hydroxylation of chemical compounds
J Nazor, R Osborne, J Liang, J Vroom, X Zhang, D Entwistle, R Voladri, ...
US Patent 10,184,117, 2019
82019
The system can't perform the operation now. Try again later.
Articles 1–20